PARP-1 May be Key to Effectiveness of PARP Inhibitors, and Now Researchers Can Image It
Penn Medicine researchers have used CRISPR/Cas9 gene editing technology to isolate a key genetic feature that could cause resistance to PARP inhibitors in patients with ovarian cancer – and they’ve also proven they have a way to see that feature using PET imaging.
Read more about PARP-1 May be Key to Effectiveness of PARP Inhibitors, and Now Researchers Can Image It